| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.33B | 36.29B | 30.45B | 35.38B | 37.30B | 32.89B |
| Gross Profit | 8.62B | 8.26B | 6.45B | 7.41B | 8.90B | 8.20B |
| EBITDA | 7.53B | 7.15B | 5.49B | 6.11B | 7.29B | 7.11B |
| Net Income | 2.89B | 2.89B | 1.84B | 2.28B | 5.36B | 2.96B |
Balance Sheet | ||||||
| Total Assets | 58.99B | 60.73B | 58.62B | 55.47B | 56.60B | 52.93B |
| Cash, Cash Equivalents and Short-Term Investments | 14.66B | 16.64B | 16.23B | 15.10B | 15.89B | 15.57B |
| Total Debt | 5.58B | 5.56B | 5.12B | 4.14B | 5.59B | 8.86B |
| Total Liabilities | 14.58B | 15.73B | 14.11B | 12.31B | 13.87B | 16.17B |
| Stockholders Equity | 44.18B | 44.75B | 44.26B | 42.92B | 42.22B | 36.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.95B | 686.00M | 1.05B | 2.70B | 4.96B |
| Operating Cash Flow | 0.00 | 7.12B | 6.54B | 5.63B | 5.40B | 7.35B |
| Investing Cash Flow | 0.00 | -4.32B | -5.83B | -3.28B | -2.06B | -2.27B |
| Financing Cash Flow | 0.00 | -2.83B | -141.00M | -3.72B | -3.52B | -3.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥83.08B | 11.63 | 15.07% | 1.74% | 15.12% | 40.72% | |
76 Outperform | ¥80.56B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
75 Outperform | ¥55.89B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
73 Outperform | ¥62.43B | 18.37 | 6.31% | 4.01% | 6.38% | 22.81% | |
70 Outperform | ¥86.04B | 10.34 | ― | 3.74% | -0.68% | -9.93% | |
70 Outperform | ¥56.76B | -468.17 | ― | 4.37% | -1.09% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |